Abstract:BACKGROUND: Endometriomas are most common during the reproductive years and have an extremely negative impact on ovarian reserve and fertility. In this case, the main method of treatment remains surgery, which inevitably injures healthy ovarian tissue. Assessing the impact of surgical treatment of endometriomas on ovarian reserve and fertility will help to optimize the management of patients of reproductive age with endometrioid cysts. AIM: The aim of this study was to evaluate the effect of surgical treatment on ovarian reserve and reproductive outcomes in patients with endometrioid cysts. MATERIALS AND METHODS: We analyzed the course of the disease in 289 patients with endometriomas. All patients underwent processing of medical histories and surgical protocols; then, 134 patients were surveyed in the long-term postoperative period (12–24 months after surgery) to gather data on complaints and age of the patients, the size of endometriomas, previous treatment, anti-Müllerian hormone level, and features of reproductive function implementation. RESULTS: Among patients who had pain before surgery, 52.8% of patients noted a complete absence of pain after surgery; in 26.4% of patients, pain significantly decreased. In 65.8% of patients who had dysmenorrhea before surgery, menstruation became painless. Among patients who complained of dyspareunia before surgical treatment, in 80% of patients, pain during sexual intercourse decreased or disappeared after surgery. After surgical treatment, 119 of 134 surveyed patients (88.8%) received drugs for hormonal therapy for endometriosis. After treatment, pregnancy occurred in 54 out of 82 patients interested in reproductive function. The average anti-Müllerian hormone level before treatment was 3.8 ± 1.8 ng/ml in the age group of 20–34 years and 1.9 ± 1.5 ng/ml in the age group of 35–45 years old; after treatment, 2.7 ± 2.0 ng/ml and 1.0 ± 1.8 ng/ml, respectively. CONCLUSIONS: Determining anti-Müllerian hormone level is one of the main methods for obtaining an idea of the patient’s ovarian reserve. At a young age and with not implemented reproductive function, it is mandatory to determine the ovarian reserve and consult a reproductive specialist before starting treatment. According to our results, surgical treatment of endometriomas is the most promising for overcoming infertility in young patients with endometriosis.

Genital endometriosis: controversial issues and alternative approaches to diagnosis and treatment

Endometriosis: Evaluation and Treatment

Future Biological Perspectives for Diagnosis and Treatment

Endometriosis, a common but enigmatic disease with many faces: current concept of pathophysiology, and diagnostic strategy

Rethinking mechanisms, diagnosis and management of endometriosis

Endometriosis and Adenomyosis: Modern Concepts of Their Clinical Outcomes, Treatment, and Management

Endometriosis: An Overview

Endometriosis – hormones and treatment

Endometriosis 1990. Current treatment approaches

New Understanding of Diagnosis, Treatment and Prevention of Endometriosis

Effichiency of contemporary methods of internal endometriosis (adenomyosis) treatment

Pathogenesis Based Diagnosis and Treatment of Endometriosis

Epidemiological aspects of chronic pelvic pain syndrome in genital endometriosis (review article)

Hormonal treatments for endometriosis: The endocrine background

Endometriosis: A concise practical guide to current diagnosis and treatment

Impact of surgical treatment of endometriomas on ovarian reserve and reproductive outcomes

Advances in the management of endometriosis: an update for clinicians

Adenomyosis and endometriosis: common features

Chronic endometritis: A protracted discussion

Advances in the medical treatment of adolescent endometriosis

Clues to revising the conventional diagnostic algorithm for endometriosis